483 related articles for article (PubMed ID: 33016929)
1. Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.
Wang L; Yang L; Wang C; Zhao W; Ju Z; Zhang W; Shen J; Peng Y; An C; Luu YT; Song S; Yap TA; Ajani JA; Mills GB; Shen X; Peng G
J Clin Invest; 2020 Nov; 130(11):5951-5966. PubMed ID: 33016929
[TBL] [Abstract][Full Text] [Related]
2. Rotavirus activates a noncanonical ATM-Chk2 branch of DNA damage response during infection to positively regulate viroplasm dynamics.
Sarkar R; Patra U; Lo M; Mukherjee A; Biswas A; Chawla-Sarkar M
Cell Microbiol; 2020 Mar; 22(3):e13149. PubMed ID: 31845505
[TBL] [Abstract][Full Text] [Related]
3. Feedback regulation of methyl methanesulfonate and ultraviolet-sensitive gene clone 81 via ATM/Chk2 pathway contributes to the resistance of MCF-7 breast cancer cells to cisplatin.
Lv J; Qian Y; Ni X; Xu X; Dong X
Tumour Biol; 2017 Mar; 39(3):1010428317694307. PubMed ID: 28347251
[TBL] [Abstract][Full Text] [Related]
4. Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS/STING signaling in gastric cancer cells.
Li C; Shen Q; Zhang P; Wang T; Liu W; Li R; Ma X; Zeng X; Yin Y; Tao K
J Exp Clin Cancer Res; 2021 Oct; 40(1):315. PubMed ID: 34625086
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.
Abdel-Fatah TM; Arora A; Alsubhi N; Agarwal D; Moseley PM; Perry C; Doherty R; Chan SY; Green AR; Rakha E; Ball G; Ellis IO; Madhusudan S
Neoplasia; 2014 Nov; 16(11):982-91. PubMed ID: 25425972
[TBL] [Abstract][Full Text] [Related]
6. ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation.
Hu M; Zhou M; Bao X; Pan D; Jiao M; Liu X; Li F; Li CY
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33290271
[TBL] [Abstract][Full Text] [Related]
7. Sustained CHK2 activity, but not ATM activity, is critical to maintain a G1 arrest after DNA damage in untransformed cells.
García-Santisteban I; Llopis A; Krenning L; Vallejo-Rodríguez J; van den Broek B; Zubiaga AM; Medema RH
BMC Biol; 2021 Feb; 19(1):35. PubMed ID: 33607997
[TBL] [Abstract][Full Text] [Related]
8. ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.
Shen J; Ju Z; Zhao W; Wang L; Peng Y; Ge Z; Nagel ZD; Zou J; Wang C; Kapoor P; Ma X; Ma D; Liang J; Song S; Liu J; Samson LD; Ajani JA; Li GM; Liang H; Shen X; Mills GB; Peng G
Nat Med; 2018 May; 24(5):556-562. PubMed ID: 29736026
[TBL] [Abstract][Full Text] [Related]
9. ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
Shen J; Peng Y; Wei L; Zhang W; Yang L; Lan L; Kapoor P; Ju Z; Mo Q; Shih IeM; Uray IP; Wu X; Brown PH; Shen X; Mills GB; Peng G
Cancer Discov; 2015 Jul; 5(7):752-67. PubMed ID: 26069190
[TBL] [Abstract][Full Text] [Related]
10. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
[TBL] [Abstract][Full Text] [Related]
11. ATM-CHK2-Beclin 1 axis promotes autophagy to maintain ROS homeostasis under oxidative stress.
Guo QQ; Wang SS; Zhang SS; Xu HD; Li XM; Guan Y; Yi F; Zhou TT; Jiang B; Bai N; Ma MT; Wang Z; Feng YL; Guo WD; Wu X; Zhao GF; Fan GJ; Zhang SP; Wang CG; Cao LY; O'Rourke BP; Liu SH; Wang PY; Han S; Song XY; Cao L
EMBO J; 2020 May; 39(10):e103111. PubMed ID: 32187724
[TBL] [Abstract][Full Text] [Related]
12. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
[TBL] [Abstract][Full Text] [Related]
13. ATM-mediated DNA double-strand break response facilitated oncolytic Newcastle disease virus replication and promoted syncytium formation in tumor cells.
Ren S; Ur Rehman Z; Gao B; Yang Z; Zhou J; Meng C; Song C; Nair V; Sun Y; Ding C
PLoS Pathog; 2020 Jun; 16(6):e1008514. PubMed ID: 32479542
[TBL] [Abstract][Full Text] [Related]
14. Ataxia-Telangiectasia Mutated (ATM) Protein Signaling Participates in Development of Pulmonary Arterial Hypertension in Rats.
Hu F; Liu C; Liu H; Xie L; Yu L
Med Sci Monit; 2017 Sep; 23():4391-4400. PubMed ID: 28894083
[TBL] [Abstract][Full Text] [Related]
15. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
Takemura H; Rao VA; Sordet O; Furuta T; Miao ZH; Meng L; Zhang H; Pommier Y
J Biol Chem; 2006 Oct; 281(41):30814-23. PubMed ID: 16905549
[TBL] [Abstract][Full Text] [Related]
16. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
17. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
[TBL] [Abstract][Full Text] [Related]
18. Lyn tyrosine kinase promotes silencing of ATM-dependent checkpoint signaling during recovery from DNA double-strand breaks.
Fukumoto Y; Kuki K; Morii M; Miura T; Honda T; Ishibashi K; Hasegawa H; Kubota S; Ide Y; Yamaguchi N; Nakayama Y; Yamaguchi N
Biochem Biophys Res Commun; 2014 Sep; 452(3):542-7. PubMed ID: 25173936
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein activates the ATM-Chk2 pathway and delays cell cycle progression.
Kim S; Lee HS; Ji JH; Cho MY; Yoo YS; Park YY; Cha HJ; Lee Y; Kim Y; Cho H
J Gen Virol; 2015 Aug; 96(8):2242-2251. PubMed ID: 25872745
[TBL] [Abstract][Full Text] [Related]
20. Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.
Bartkova J; Hoei-Hansen CE; Krizova K; Hamerlik P; Skakkebæk NE; Rajpert-De Meyts E; Bartek J
Mol Oncol; 2014 Dec; 8(8):1667-78. PubMed ID: 25066726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]